Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)

? Special Offer?Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

? New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
Brand: ProteoGenix

Blinatumomab Biosimilar – Anti-CD19, CD3E mAb – Research Grade

Clonality:
Monoclonal Antibody
Isotype:
(scFv-kappa-heavy)-(scFv-heavy-kappa); His-Tag

200.00

100ug +200 loyalty points
Size
  • In Stock
  • Free shipping in EU on orders > €500
  • Wide range of unique reagents
  • Fast worldwide delivery

Blinatumomab Biosimilar - Anti-CD19, CD3E mAb - Research Grade

Product name Blinatumomab Biosimilar - Anti-CD19, CD3E mAb - Research Grade
Source CAS 853426-35-4
Species Mus musculus
Expression system Mammalian
Molecular weight 54.1kDa
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB
Aliases /Synonyms Blinatumomab,AMG103,BITE MT-103,MEDI-538,MT103,bscCD19xCD3,CD19, CD3E,anti-CD19, CD3E
Reference PX-TA1067
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype (scFv-kappa-heavy)-(scFv-heavy-kappa); His-Tag
Clonality Monoclonal Antibody
Product name Blinatumomab Biosimilar - Anti-CD19, CD3E mAb - Research Grade
Source CAS 853426-35-4
Species Mus musculus
Expression system Mammalian cells
Molecular weight 54.1kDa
Purity >85%
Buffer PBS buffer PH7.5
Delivery condition Blue ice (+4°C)
Delivery lead time in business days 3-5 days if in stock; 3-5 weeks if production needed
Delivery Time 3-5 days if in stock; 3-5 weeks if production needed
Storage condition store at -80°C
Brand ProteoGenix
Applications ELISA,WB,,,
Aliases /Synonyms Blinatumomab,AMG103,BITE MT-103,MEDI-538,MT103,bscCD19xCD3,CD19, CD3E,anti-CD19, CD3E
Reference PX-TA1067
Note For research use only. Not suitable for clinical or therapeutic use.
Isotype (scFv-kappa-heavy)-(scFv-heavy-kappa); His-Tag
Clonality Monoclonal Antibody

General information on Anti-CD19/CD3E(Homo sapiens) (Blinatumomab) Monoclonal Antibody

Blinatumomab is a monoclonal antibody constructed by BiTE (bispecific T cell engagers), which is used to treat relapsed or refractory B cell precursor acute lymphoblastic leukemia (ALL) with negative Philadelphia chromosome. Blinatumomab is available as a drug under the Blincyto™ brand.

  • Park AK, Monroy I, Ren Y, Lu C, Chaurasiya S, Valencia H, et al. Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors. Journal for ImmunoTherapy of Cancer. 2025;13:e011051. https://doi.org/10.1136/jitc-2024-011051

There are no reviews yet.

Be the first to review “Blinatumomab Biosimilar – Anti-CD19, CD3E mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Can’t find what you need?

Our catalog doesn’t cover everything — but our team does. Whether you need a custom antibody, a specific protein variant, or a bulk order, our scientists are here to help.

Contact Our Team Book a Call

Cart (0 Items)

Your cart is currently empty.

View Products